The relation of pituitary adenomas invasiveness and the proliferative index measured by immunoexpression of topoisomerase IIα.
暂无分享,去创建一个
B. Kwinta | Małgorzata Trofimiuk-Muldner | D. Adamek | A. Wilk | R. Krzyżewski | K. Stachura | E. Grzywna
[1] C. Melincovici,et al. Diagnostic criteria in invasive pituitary adenomas , 2016 .
[2] A. Chacko,et al. Clinicopathological correlates of extrasellar growth patterns in pituitary adenomas , 2015, Journal of Clinical Neuroscience.
[3] S. Ceylan,et al. Cavernous sinus invasion and effect of immunohistochemical features on remission in growth hormone secreting pituitary adenomas. , 2015, Turkish neurosurgery.
[4] A. Hubalewska-Dydejczyk,et al. Topoisomerase IIα as a prognostic factor in pituitary tumors. , 2014, Polskie Archiwum Medycyny Wewnetrznej.
[5] Jinna Kim,et al. Evaluation of MRI Criteria for Cavernous Sinus Invasion in Pituitary Macroadenoma , 2014, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[6] Wei Gao,et al. Expression of DNA topoisomerase II-α: Clinical significance in laryngeal carcinoma , 2014, Oncology letters.
[7] A. Heaney. Management of aggressive pituitary adenomas and pituitary carcinomas , 2014, Journal of Neuro-Oncology.
[8] B. Scheithauer,et al. Clinicopathologic correlates of giant pituitary adenomas , 2009, Journal of Clinical Neuroscience.
[9] A. Falini,et al. Tumours , 2008, Neurological Sciences.
[10] Patrick J. Maloney. Handbook of Neurosurgery , 2008, The Yale Journal of Biology and Medicine.
[11] Michael Buchfelder,et al. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. , 2007, European journal of endocrinology.
[12] A. Doerfler,et al. Imaging of sellar and parasellar lesions , 2007, Clinical Neurology and Neurosurgery.
[13] PhD George Kontogeorgos MD. Classification and pathology of pituitary tumors , 2007, Endocrine.
[14] G. Kontogeorgos. Predictive Markers of Pituitary Adenoma Behavior , 2006, Neuroendocrinology.
[15] H. Koh,et al. Clinical Significance of Ki-67 Labeling Index in Pituitary Macroadenoma , 2005, Journal of Korean medical science.
[16] M. Buchfelder,et al. Clinical review: Diagnosis and management of pituitary carcinomas. , 2005, The Journal of clinical endocrinology and metabolism.
[17] R. Fahlbusch,et al. The WHO classification of pituitary tumours: a combined neurosurgical and neuropathological view , 2005, Acta Neuropathologica.
[18] A. Grossman. The 2004 World health organization classification of pituitary tumors: is it clinically helpful? , 2005, Acta Neuropathologica.
[19] R. Fahlbusch,et al. Transsphenoidal surgery of parasellar pituitary adenomas , 2005, Acta Neurochirurgica.
[20] J. Hainfellner,et al. Expression of cell proliferation markers in pituitary adenomas – correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIα , 2004, Acta Neurochirurgica.
[21] A. Goel,et al. Giant pituitary tumors: a study based on surgical treatment of 118 cases. , 2004, Surgical neurology.
[22] J. Wass,et al. Are Markers of Proliferation Valuable in the Histological Assessment of Pituitary Tumours? , 1999, Pituitary.
[23] B. Scheithauer,et al. Topoisomerase IIα Expression in Pituitary Adenomas and Carcinomas: Relationship to Tumor Behavior , 2002, Modern Pathology.
[24] S. Ozalp,et al. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma. , 2002, European journal of gynaecological oncology.
[25] M. Koshiyama,et al. Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas. , 2001, Anticancer research.
[26] G. Stalla,et al. Hypophysentumoren und Kraniopharyngeome. , 2001 .
[27] L. Brunereau,et al. Cavernous sinus invasion by pituitary adenoma: MR imaging. , 2000, Radiology.
[28] Rebecca Lynn Johnson,et al. Topoisomerase IIα Expression in Breast Cancer: Correlation with Outcome Variables , 2000, Modern Pathology.
[29] C. Matula,et al. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. , 1993, Neurosurgery.
[30] G. Faglia. Epidemiology and pathogenesis of pituitary adenomas. , 1993, Acta endocrinologica.
[31] A. Elster. Imaging of the sella: anatomy and pathology. , 1993, Seminars in ultrasound, CT, and MR.
[32] F. Boege,et al. The measurement of nuclear topoisomerase II inhibition in vitro: a possible tool for detecting resistance on a subcellular level in haematopoietic malignancies. , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[33] P. Kleihues,et al. Growth rate of human pituitary adenomas. , 1987, Journal of neurosurgery.
[34] C. Zee,et al. Cavernous sinus invasion by pituitary adenomas. , 1985, AJR. American journal of roentgenology.
[35] G. di Chiro,et al. The volume of the sella turcica. , 1962, The American journal of roentgenology, radium therapy, and nuclear medicine.